Hereditary continuous muscle fiber activity

Hereditary continuous muscle fiber activity, also known as Isaacs syndrome or neuromyotonia when it occurs in hereditary form, is a rare neuromuscular disorder characterized by persistent and widespread involuntary muscle activity originating from peripheral nerves. The condition is caused by hyperexcitability of peripheral motor nerves, leading to continuous muscle fiber contraction even during sleep or under general anesthesia. The hereditary form is distinguished from the more common acquired autoimmune form (which is associated with antibodies against voltage-gated potassium channels). The disease primarily affects the peripheral nervous system and skeletal muscles throughout the body. Key clinical features include myokymia (visible undulating rippling movements of muscles), muscle stiffness, cramps, pseudomyotonia (delayed muscle relaxation after voluntary contraction), and excessive sweating (hyperhidrosis). Patients may also experience muscle hypertrophy due to constant muscle activity, difficulty relaxing the grip, and impaired gait. Electromyography (EMG) characteristically shows continuous motor unit activity with doublet, triplet, or multiplet discharges that persist even during sleep. Treatment is symptomatic and primarily involves medications that reduce peripheral nerve excitability. Anticonvulsants such as carbamazepine and phenytoin are considered first-line therapies and can significantly reduce muscle stiffness and cramping. Other membrane-stabilizing agents, including lamotrigine and mexiletine, may also be beneficial. The hereditary form generally follows a chronic but non-progressive or slowly progressive course, and many patients achieve meaningful symptom relief with appropriate pharmacological management.

Common questions about Hereditary continuous muscle fiber activity